Induction of apoptosis in mouse spleen cells by Ginsenoside Rp1

마우스 비장세포에서 Ginsenoside Rp1의 세포자멸사 유도

  • Oh, Young-Kyun (Laboratory of Veterinary Pharmacology, College of Veterinary Medicine, Jeju National University) ;
  • Joo, Hong-Gu (Laboratory of Veterinary Pharmacology, College of Veterinary Medicine, Jeju National University)
  • 오영균 (제주대학교 수의과대학 수의약리학실험실) ;
  • 주홍구 (제주대학교 수의과대학 수의약리학실험실)
  • Received : 2013.03.11
  • Accepted : 2013.07.18
  • Published : 2013.09.30


Ginsenoside Rp1 is one of ginseng saponins with chemotherapeutic activity. In this study, we investigated the effects of Rp1 on spleen cells. Spleen is a major immune organ consisted of crucial immune cells, such as T lymphocytes, B lymphocytes, natural killer cells, and some antigen-presenting cells. Although the anti-tumor potential of Rp1 was studied, the effects of Rp1 on immune cells have not investigated yet. A viability assay using 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT), flow cytometric analysis, Western blot analysis were used to detect cellular changes on Rp1-treated spleen cells. MTT assay showed that Rp1 decreased the viability of spleen cells. To further investigate the effects of Rp1 on activated spleen cells, we treated lipopolysaccharide (LPS) as a representative inflammatory agent and Rp1 on spleen cells in a combination. The surface expression levels of activation markers for lymphocytes, CD25 and CD69 were measured. Apoptotic analysis revealed the cytotoxic effects of Rp1 on both na$\ddot{i}$ve and activated cells, and the expression pattern of some apoptosis-related proteins was correlated to apoptotic events of cells. Taken together, ginsenoside Rp1 increases the cellular death of spleen cells and also inhibits the LPS-induced activation of spleen cells.


Supported by : 농림축산식품부


  1. Abbas AK, Lichtman AH. Cellular and Molecular Immunology. 5th ed. pp. 31-32, Saunders, Philadelphia, 2003.
  2. Cesta MF. Normal Structure, Function, and Histology of the Spleen. Toxicol Pathol 2006, 34, 455-465.
  3. Chen F, Chen Y, Kang X, Zhou Z, Zhang Z, Liu D. Antiapoptotic function and mechanism of ginseng saponins in Rattus pancreatic $\beta$-cells. Biol Pharm Bull 2012, 35, 1568- 1573.
  4. Fearon DT. The expansion and maintenance of antigenselected $CD8^+$ T cell clones. Adv Immunol 2007, 96, 103-139.
  5. Jeong BE, Ko EJ, Joo HG. Cytoprotective effects of fucoidan, an algae-derived polysaccharide on 5-fluorouraciltreated dendritic cells. Food Chem Toxicol 2012, 50, 1480-1484.
  6. Kenarova B, Neychev H, Hadjiivanova C, Petkov VD. Immunomodulating activity of ginsenoside Rg1 from Panax ginseng. Jpn J Pharmacol 1990, 54, 447-454.
  7. Kim BH, Cho JY. Regulatory role of ginsenoside Rp1, a novel ginsenoside derivative, on CD29-mediated cell adhesion. Planta Med 2009, 75, 316-320.
  8. Kim BH, Lee YG, Park TY, Kim HB, Rhee MH, Cho JY. Ginsenoside Rp1, a ginsenoside derivative, blocks lipopolysaccharide-induced interleukin-1$\beta$ production via suppression of the NF-$\kappa$B pathway. Planta Med 2009, 75, 321-326.
  9. Kim JM, Joo HG. Immunostimulatory effects of $\beta$-glucan purified from Paenibacillus polymyxa JB115 on mouse splenocytes. Korean J Physiol Pharmacol 2012, 16, 225-230.
  10. Kim SM, Lee SY, Yuk DY, Moon DC, Choi SS, Kim Y, Han SB, Oh KW, Hong JT. Inhibition of NF-$\kappa$B by ginsenoside Rg3 enhances the susceptibility of colon cancer cells to docetaxel. Arch Pharm Res 2009, 32, 755-765.
  11. Kumar A, Kumar M, Panwar M, Samarth RM, Park TY, Park MH, Kimura H. Evaluation of chemopreventive action of Ginsenoside Rp1. Biofactors 2006, 26, 29-43.
  12. Kumar A, Kumar M, Park TY, Park MH, Takemoto T, Terado T, Kitano M, Kimura H. Molecular mechanisms of ginsenoside Rp1-mediated growth arrest and apoptosis. Int J Mol Med 2009, 24, 381-386.
  13. Park EK, Choo MK, Han MJ, Kim DH. Ginsenoside Rh1 possesses antiallergic and anti-inflammatory activities. Int Arch Allergy Immunol 2004, 133, 113-120.
  14. Park TY, Park MH, Shin WC, Rhee MH, Seo DW, Cho JY, Kim HM. Anti-metastatic potential of ginsenoside Rp1, a novel ginsenoside derivative. Biol Pharm Bull 2008, 31, 1802-1805.
  15. Sancho D, Gomez M, Sanchez-Madrid F. CD69 is an immunoregulatory molecule induced following activation. Trends Immunol 2005, 26, 136-140.